BCB-276 cell therapy for pediatric brain cancer gets new FDA status
BCB-276, an experimental cell therapy that Brainchild Bio…
Glioma
Glioma overview
Gliomas are a group of brain tumors that arise from glial cells, a type of support cell of the central nervous system, or CNS, which comprises the brain and spinal cord. They make up about one-quarter of all tumors that start in the brain (primary brain tumors), occurring in about 6.6 per 100,000 people every year. They also account for more than 80% of all malignant, or cancerous, brain tumors.
Read moreGlioma treatment
Treatment for gliomas, a diverse group of tumors that form in the brain and spinal cord, can involve a variety of approaches, including surgery, radiation therapy, and chemotherapy, as well as a range of supportive treatments.
Read moreNews
New partners to help develop CAR T-cell therapy for brain cancer
Optieum Biotechnologies and Genezen are teaming up…
Viralgen, Trogenix collaborate on glioblastoma treatment
Contract development and manufacturing organization Viralgen said it has…
Supporters to #GoGrayinMay for Brain Tumor Awareness Month
Each May marks Brain Tumor Awareness Month, with annual…
BCB-276 for DIPG brain cancer named FDA breakthrough therapy
The U.S. Food and Drug Administration (FDA) has granted…
Proteins could be biomarkers for glioma-related epilepsy: Study
The LY6H and GRM3 proteins could serve as potential…
